Alzheimer's disease causation by copper toxicity and treatment with zinc

Frontiers in Aging Neuroscience

Volumn 6, Issue MAY, 2014, Pages

  Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Cognition; Inorganic copper; Serum free copper; Zinc deficiency

Indexed keywords

COPPER; DRINKING WATER; ZINC;

AGE; ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING; COGNITION; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DEVELOPED COUNTRY; DIET SUPPLEMENTATION; EPIDEMIC; FAT INTAKE; GENE CONTROL; HUMAN; LIPID DIET; MINI MENTAL STATE EXAMINATION; NONHUMAN; PATHOLOGY; PILL; PREVALENCE; RISK FACTOR; WILSON DISEASE; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 84901312587     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00092     Document Type: Article

References (35)

1. Adlard, P. A., Parncutt, J. M., Finkelstein, D. I., and Bush, A. I. (2010). Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J. Neurosci. 30, 1631-1636. doi: 10.1523/jneurosci.5255-09.2010.
2. Alzheimer's Association (2010). Alzheimer's Disease Facts and Figures. 1-74.
3. Baum, L., Chan, I. H., Cheung, S. K., Goggins, W. B., Mok, V., Lam, L., et al. (2010). Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173-179. doi: 10.1007/s10534-009-9277-5.
4. Boyd, W. (1938). A Textbook of Pathology: An Introduction to Medicine. Philadelphia: Lea and Febiger.
5. Brewer, G. J. (2011). Issues raised involving the copper hypotheses in the causation of Alzheimer's disease. Int. J. Alzheimers Dis. 2011:537528. doi: 10.4061/2011/537528.
6. Brewer, G. J. (2012). Copper excess, zinc deficiency and cognition loss in Alzheimer's disease. Biofactors 38, 107-113. doi: 10.1002/biof.1005.
7. Brewer, G. J., Kanzer, S. H., Zimmerman, E. A., Molho, E. S., Celmins, D. F., Heckman, S. M., et al. (2010). Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am. J. Alzheimers Dis. Other Demen. 25, 572-575. doi: 10.1177/1533317510382283.
8. Bucossi, S., Mariani, S., Ventriglia, M., Polimanti, R., Gennarelli, M., Bonvicini, C., et al. (2011). Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's disease. Int. J. Alzheimers Dis. 2011:973692. doi: 10.4061/2011/973692.
9. Bucossi, S., Polimanti, R., Mariani, S., Ventriglia, M., Bonvicini, C., Migliore, S., et al. (2012). Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease. J. Alzheimers Dis. 29, 913-919. doi: 10.3233/JAD-2012-111997.
10. Constantinidis, J. (1992). Treatment of Alzheimer's disease by zinc compounds. Drug Dev. Res. 27, 1-14. doi: 10.1002/ddr.430270102.
11. Corona, C., Masciopinto, F., Silvestri, E., Viscovo, A. D., Lattanzio, R., Sorda, R. L., et al. (2010). Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis. 1:e91. doi: 10.1038/cddis.2010.73.
12. Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., et al. (2011). The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity. J. Neurochem. 119, 220-230. doi: 10.1111/j.1471-4159.2011.07402.x.
13. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117. doi: 10.1016/s0140-6736(05)67889-0.
14. Gowers, W. R. (1888). A Manual of Diseases of the Nervous System. Philadelphia: P Blakiston, Son and Co.
15. Grant, W. B. (1997). Dietary links to Alzheimer's disease. Alzheimer's Dis. Rev. 2, 42-55.
16. Hill, G. M., Brewer, G. J., Juni, J. E., Prasad, A. S., and Dick, R. D. (1986). Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance. Am. J. Med. Sci. 292, 344-349. doi: 10.1097/00000441-198612000-00002.
17. James, S. A., Volitakis, I., Adlard, P. A., Duce, J. A., Masters, C. L., Cherny, R. A., et al. (2012). Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic. Biol. Med. 52, 298-302. doi: 10.1016/j.freeradbiomed.2011.10.446.
18. Kessler, H., Bayer, T. A., Bach, D., Schneider-Axmann, T., Supprian, T., Herrmann, W., et al. (2008). Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. J. Neural Transm. 115, 1181-1187. doi: 10.1007/s00702-008-0080-1.
19. Klevay, L. M. (2008). Alzheimer's disease as copper deficiency. Med. Hypotheses 70, 802-807. doi: 10.1016/j.mehy.2007.04.051.
20. Miyata, M., and Smith, J. D. (1996). Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14, 55-61. doi: 10.1038/ng0996-55.
21. Moalem, S., Percy, M. E., Andrews, D. F., Kruck, T. P., Wong, S., Dalton, A. J., et al. (2000). Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am. J. Med. Genet. 93, 58-66. doi: 10.1002/1096-8628(20000703)93:1<58::aid-ajmg10>3.0.co;2-l.
22. Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Schneider, J. A., Wilson, R. S., et al. (2006). Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch. Neurol. 63, 1085-1088. doi: 10.1001/archneur.63.8.1085.
23. Osler, W. (ed.) (1910). Modern Medicine in Theory and Practice. Philadelphia and New York: Lea and Febiger.
24. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'agostino, R. B., et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483. doi: 10.1056/NEJMoa011613.
25. Singh, I., Sagare, A. P., Coma, M., Perlmutter, D., Gelein, R., Bell, R. D., et al. (2013). Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. U S A 110, 14771-14776. doi: 10.1073/pnas.1302212110.
26. Sparks, D. L., Friedland, R., Petanceska, S., Schreurs, B. G., Shi, J., Perry, G., et al. (2006). Trace copper levels in the drinking water, but not zinc or aluminum, influence CNS Alzheimer-like pathology. J. Nutr. Health Aging 10, 247-254.
27. Sparks, D. L., and Schreurs, B. G. (2003). Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. U S A 100, 11065-11069. doi: 10.1073/pnas.1832769100.
28. Squitti, R., Barbati, G., Rossi, L., Ventriglia, M., Dal Forno, G., Cesaretti, S., et al. (2006). Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid and h-tau. Neurology 67, 76-82. doi: 10.1212/01.wnl.0000223343.82809.cf.
29. Squitti, R., Bressi, F., Pasqualetti, P., Bonomini, C., Ghidoni, R., Binetti, G., et al. (2009). Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease. Neurology 72, 50-55. doi: 10.1212/01.wnl.0000338568.break28960.3f.
30. Squitti, R., Pasqualetti, P., Dal Forno, G., Moffa, F., Cassetta, E., Lupoi, D., et al. (2005). Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64, 1040-1046. doi: 10.1212/01.wnl.0000154531.79362.23.
31. Takeda, A. (2010). Insight into glutamate excitotoxicity from synaptic zinc homeostasis. Int. J. Alzheimers Dis. 2011:491597. doi: 10.4061/2011/491597.
32. Ueda, K., Kawano, H., Hasuo, Y., and Fujishima, M. (1992). Prevalence and etiology of dementia in a Japanese community. Stroke 23, 798-803. doi: 10.1161/01.str.23.6.798.
33. Waldman, M., and Lamb, M. (2005). Dying for a Hamburger: Modern Meat Processing and the Epidemic of Alzheimer's Disease. New York: Thomas Dune Books/St. Martin's Press.
34. White, L., Petrovitch, H., Ross, G. W., Masaki, K. H., Abbott, R. D., Teng, E. L., et al. (1996). Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia aging study. JAMA 276, 955-960. doi: 10.1001/jama.276.12.955.
35. 2 variant does confer a risk for Alzheimer's disease in caucasians. J. Alzheimers Dis. 5, 423-427.